Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Considerations for conducting developmental neuroimaging research on mental health topics
    Published on 2025-08-30
    3 months ago
  • Anxiety and depression in emerging adults: The STAND program as a model of scalable screening and intervention
    Published on 2025-08-29
    3 months ago
  • Maternal separation disrupts noradrenergic control of adult coping behaviors
    Published on 2025-08-28
    3 months ago
  • Myelination across the autism spectrum: therapeutic targeting of the oligodendrocyte lineage and myelination defects
    Published on 2025-08-28
    3 months ago
  • Targeting GPR3 as a novel approach for nicotine cessation therapeutic development
    Published on 2025-08-27
    3 months ago
  • Connectome-based encoding of subjective drug responses to acute oral methamphetamine
    Published on 2025-08-27
    3 months ago
  • For those with schizophrenia, does cannabidiol make cannabis use safer?
    Published on 2025-08-26
    3 months ago
« Previous 1 … 10 11 12 13 14 … 143 Next »
Journal of Psychopharmacology
  • Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression
    Published on 2025-07-01
    5 months ago
  • Urological symptoms following ketamine treatment for psychiatric disorders: A systematic review
    Published on 2025-06-30
    5 months ago
  • Effects of initial nicotine exposure on cognition and nicotine reinforcement among non-smoking young adults with and without attention deficit hyperactivity disorder
    Published on 2025-06-28
    5 months ago
  • OAV and 5D-ASC for Brazilian Portuguese: A validation and adaptation study
    Published on 2025-06-28
    5 months ago
  • Acute effects of 150 mg caffeine on subjective, physiological, and behavioral components of anxiety in panic disorder and healthy controls – A randomized placebo-controlled crossover trial
    Published on 2025-06-27
    5 months ago
  • Fluoroquinolones and risk of nightmares: A literature review and disproportionality analysis using individual case safety reports from Food and Drug Administration Adverse Event Reporting System database
    Published on 2025-06-27
    5 months ago
  • A randomized, double-blind, placebo-controlled, Phase 1 study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of an immediate-release oral ketamine capsule in healthy volunteers
    Published on 2025-06-20
    6 months ago
« Previous 1 … 10 11 12 13 14 … 134 Next »
European Neuropsychopharmacology
  • Comparative mortality risk of antipsychotics in 41,695 patients with schizophrenia: an 11-year population-based cohort study in Hong Kong
    Published on 2025-05-23
    7 months ago
  • Pharmacological treatments for atypical depression: A systematic review and network meta-analysis of randomized controlled trials
    Published on 2025-05-23
    7 months ago
  • Antidepressant use during pregnancy and risk of obstetrics and neonatal outcomes: A propensity score-weighted population-based cohort study in 2003–2018
    Published on 2025-05-23
    7 months ago
  • Functioning Assessment Short Test (FAST): validity and reliability in adolescent and young adults with Borderline Personality Disorder (BPD)
    Published on 2025-05-23
    7 months ago
  • Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis
    Published on 2025-05-23
    7 months ago
  • Attention to the quality of methods is critical for valuable research: some examples relevant for animal models of psychiatric disorders
    Published on 2025-05-23
    7 months ago
  • Association between major cardiovascular events and esketamine: A disproportionality analysis in the WHO pharmacovigilance database
    Published on 2025-04-16
    8 months ago
« Previous 1 … 10 11 12 13 14 … 153 Next »

   Pharma Pub